Merck and Mayo Clinic are partnering to use AI technology and large-scale clinical data to speed drug development in MS and ...

Continued treatment with Briumvi provided sustained clinical benefits to patients with relapsing MS, particularly when ...

Columnist Ben Hofmeister may rely on others for daily living, but trusting people isn't the same as giving up, he says.

UCSF is teaming up with Nektar to study NKTR-0165, an experimental antibody that activates the TNFR2 receptor, as a treatment ...

Breastfeeding for longer in infancy may be associated with lower disease severity and a later onset of MS in adulthood, a ...

A collaboration will test whether changes in a person’s voice can help detect multiple sclerosis, potentially enabling a ...

Immunic raised funds to support Phase 3 clinical trials of vidofludimus calcium for MS and transition into a commercial-stage company.

With this year's Read-a-Thon for kids, running through March, MS Canada hopes to raise CA$65,000 to support research and community programs.

Some MS diets may help lower inflammation marker levels, but evidence from clinical trials remains limited, according to a new review paper.

After struggling during seasons when MS took center stage, columnist Ahna Crum is enjoying the quieter days where it's only ...

A type of immune cell targeting the Epstein-Barr virus may play a key role in driving multiple sclerosis (MS), a study found.

TG Therapeutics is gearing up for a new clinical trial, dubbed ULTIMATE, to test Briumvi in children and adolescents with ...